Cancer risk from medical radiation may have been overestimated: researcher

December 1, 2010, Radiological Society of North America

The risk of developing radiation-induced cancer from computed tomography (CT) may be lower than previously thought, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

"Radiation from has gotten a tremendous amount of attention in recent years," said Aabed Meer, an M.D. candidate at Stanford University in Palo Alto, Calif. "This is one of the first studies to track CT utilization in such a large population."

The researchers conducted a using Medicare claims from 1998 through 2005 to analyze the distribution of CT scans, determine the ionizing radiation exposure associated with the exams and estimate the associated cancer risk in a population of .

"The study focused on the elderly Medicare population, which receives the highest amount of per capita radiation," Meer said. "We analyzed more than 10 million records from the Medicare claims database."

The data were studied in two groups, including 5,267,230 records from 1998 through 2001 and 5,555,345 records from 2002 through 2005. For each group, the researchers analyzed the number and types of CT scans that each patient received to determine the percentage of patients exposed to "low" radiation doses of 50 millisieverts (mSv) to 100mSv and "high" radiation doses, in excess of 100mSv. They then used standard models to estimate the number of cancers induced.

CT scans of the head were the most common examinations, representing 25 percent of the first group and 30 percent of the second group. However, abdominal CT delivered the greatest proportion of radiation, accounting for approximately 40 percent of the total in each group. Imaging of the pelvis and chest represented the second and third largest sources of radiation.

From 1998 to 2001, 42 percent of patients underwent CT scans. From 2002 to 2005, 49 percent of patients underwent CT scans. The percentage of patients exposed to in both the low and high ranges approximately doubled from the first group to the second group.
The researchers found this to be consistent with the increasing use of high-speed CT in patient diagnosis and management.

Cancer incidences related to from CT were estimated to be 0.02 percent and 0.04 percent of the two groups, respectively.

"Our findings indicate a significantly lower risk of developing cancer from CT than previous estimates of 1.5 percent to 2.0 percent of the population," said coauthor Scott Atlas, M.D., chief of neuroradiology at the Stanford University Medical Center. "Regardless, the increasing reliance on CT scans underscores the importance of monitoring CT utilization and its consequences."

Related Stories

Recommended for you

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.